ImpactOS
See an example

Gilead Sciences

Companies and groups · United States

In these lists: Medicines

Declared lobbying cost
€1,000,000 – €1,249,999 Financial year 02/2024-01/2025
Commission meetings
6
Full-time staff on EU lobbying
2.2
European Parliament access passes
2
Registered since
23 Feb 2016
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Budget, Business and industry, Competition, Public health, Research and innovation, Trade

Medicines and food topics they name

EU medicines law, Critical medicines, Health technology assessment

EU laws and policies they declare following15
  • EU initiatives relevant to HIV/AIDS, Hepatitis / Liver diseases, Cell Therapies and oncology
  • ATMP Regulation
  • EU IP policy
  • EU research policy
  • EU trade policy
  • Health Systems Performance Assessment
  • Health Technology Assessment & Market Access
  • Industrial policy
  • Outcomes-based healthcare systems
  • General Pharmaceutical Legislation
  • EU Biotech Act
  • Digital Health
  • Europe's Beating Cancer Plan
  • SoHO legislation
  • Sustainable Development Goals

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Commissioner

    Published record
  2. With the Cabinet

    Published record
  3. With the Commissioner

    Olivér Várhelyi

    Life Sciences Roundtable

    Published record
  4. With the Cabinet

    Hadja Lahbib

    HIV prevention

    Published record
  5. With the Commissioner

    Michael McGrath

    Exchange of views on issues relating to competitiveness and corporate sustainability

    Published record
  6. With the Cabinet

    Raffaele Fitto

    General Exchange on the Company’s Activities

    Published record

Official entries

Checked against sources on 11 Nov 2026